US FDA’s ODAC: The Advisory Committee That Can Only Say ‘No’

 
• By Michael McCaughan

It has been more than two years since a sponsor went before the Oncologic Drugs Advisory Committee and won a favorable vote on approval of a new drug application. Can FDA really expect an advisory committee to keep saying ‘no’ all the time?

FDA stop sign. Sarah Silbiger/Getty Images
• Source: Sarah Silbiger/Getty Images

More from US FDA Performance Tracker

More from Regulatory Trackers